Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection
Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection
Recruiting · NCT06734260 · Registry updated 2025-12-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection | Helicobacter Pylori Eradication Rate | Recruiting | Phase 3 | 2025-12-05 | NCT06734260 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eighth Affiliated Hospital, Sun Yat-sen University | 20 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eighth Affiliated Hospital,Sun Yet-san University | Shenzhen | China | 1 |
| Puning Overseas Chinese Hospital | Puning | China | 1 |
| The Sixth Affiliated Hospital of Sun Yat-sen University | Guangzhou | China | 34 |
| Xiangyang Hospital of Traditional Chinese Medicine | Xiangyang | China | 2 |